Production of pdna vaccine expressing flsc
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272201600010C
- Awardee
-
Profectus Biosciences, Inc. UEI DDRUDKNS37N8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $74,089
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2014014 Solicitation number
- Staged Vaccine Development Award Notice · Posted Aug 19, 2014
- Contract value 2% obligated
-
- $74,088.98 Current, with exercised options
- $4,214,664.98 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,200 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $75,289 |
About this award
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Profectus Biosciences, Inc., a small business. The contract, valued at $4,214,664.98, is for the production of a pDNA vaccine expressing FLSC as part of the agency's Staged Vaccine Development program. The contract does not have a set-aside designation. The contract supports the development of novel vaccine technologies and strategies, as well as the production of specific vaccines, such as the pDNA vaccine expressing FLSC and HIV-1 vaccine candidates. Profectus Biosciences, Inc. has a consistent history of providing biomedical research and development services to NIAID.
Quick answers
Who was awarded contract HHSN272201600010C?
HHSN272201600010C was awarded to Profectus Biosciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 23, 2016.
How much is contract HHSN272201600010C worth?
The government has obligated $74,089 on HHSN272201600010C. Its potential value, with all options, is $4,214,665.
Was contract HHSN272201600010C competed?
The extent of competition for HHSN272201600010C was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award